Αρχική World News A Cancer Revolution comes to Manchester: Patrick’s review

A Cancer Revolution comes to Manchester: Patrick’s review

Patrick and Pam

Patrick and his wife Pam, who died of bowel cancer, aged 52.

How exactly do you create an exhibition looking at the hugely complex and emotive subject of cancer?

You do exactly what the Science Museum has done in its superb exhibition, Cancer Revolution: Science, Innovation and Hope, which I had the pleasure of attending last month.

Cancer is one of the greatest challenges facing the world today. It’s a complex disease and the science and innovation behind is just as complicated. On top of that, there are so many myths and misunderstandings surrounding it.

All these aspects are tackled head on in the most engaging, accessible and informative way.

What makes this exhibition so successful, though, is that it puts people affected by cancer at the very centre of the story.

The people behind the innovations

As you walk in, one of the first things you see is a history of cancer starting with a dinosaur bone, which is not something I ever expected to see at such an exhibition. The exhibition then moves from the pre-historic to the latest technologies and immunotherapies that are advancing care today.

It’s a very visual exhibition, housing a wide range of historical artefacts, models, sculptures, videos, audio stories and personal objects.

Throughout, you get to see scientists as real people, who are passionate and dedicated to improving outcomes. And in each section we see people affected by cancer and reflect on their personal objects, thoughts and memories, something I’m sure we can all relate to in our own individual way.

Diary cancer revolution

Pam’s diary, which Patrick donated to the exhibition.

I had the honour and privilege to supply an artefact that’s included in the exhibition. It is a simple, factual “diary” of my wife Pam’s final two weeks before she died from bowel cancer, aged just 52. It was a hugely emotional experience seeing it on display and reliving those last few days with her. It is a reality of cancer for some and the ‘end of life’ section doesn’t shy away from this reality.

There are other personal artefacts that represent the full range of people’s experiences. Those who were diagnosed early, treated successfully and those who are still in treatment. Each object is very personal – one was a view from someone’s widow that motivated them to get up every day to face whatever was in store during their treatment.

These are what make sense of the research. The science and innovation somehow seem so much more accessible and real. The exhibition is a great credit to all involved, including Cancer Research UK and the patient involvement team that helped the Science Museum Group’s team to create it.

Hope for the future

Patrick at the exhibition in Manchester.

Patrick at the exhibition in Manchester.

Along with the themes of science and innovation the final theme is one of hope.

It is inspiring to see some of the latest innovations that will improve cancer outcomes in the very near future. I was reminded of Cancer Research UK’s bold ambition to get to 3 in 4 surviving cancer by 2034 and leaving the exhibition I felt more optimistic that this really is an achievable target.

I felt inspired and motivated to keep volunteering, to keep fundraising in the knowledge of the life saving innovations being developed now. Such innovations won’t benefit Pam, but she now has 3 grandchildren. They will never get to meet her but in 2034 they will be aged 16, 14 and 12 and I left the exhibition feeling optimistic that they will benefit from that world where more people survive cancer.

I can’t recommend this exhibition highly enough. I guarantee you’ll come away not just informed but hugely hopeful and optimistic for the future.

Patrick is a member of Cancer Research UK’s Patient Involvement Network

The Science Museum Group, with support from us, presents Cancer Revolution: Science, innovation and hope, which recently opened at the Science and Industry Museum in Manchester, and runs until March 2022.

The exhibition will be opening at the Science Museum in London in Summer 2022. If you aren’t able to attend in person at the moment, you can learn about some of the groundbreaking research featured in the museum online instead.

Learn about the research online

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Breast Cancer Survivor Invents Warming Bra Insert to Combat Cold Feeling of Breast Implants

In 2013, Kristen Carbone, of Providence, Rhode Island, had a preventative mastectomy to help protect herself against breast cancer after her mother died of...

FDA Approves Daratumumab plus Hyaluronidase-fihj, Carfilzomib, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

On 30 November 2021, the US Food and Drug Administration (FDA) approved daratumumab plus hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen,...

Thanks For Making This GivingTuesday Our Best One Yet!

We set ambitious goals for GivingTuesday, but they were driven by a time of great need. With your help, we hoped to provide food and...

Over 600 people in England set to benefit from innovative lung cancer treatment

<img width="620" height="348" src="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg" class="attachment-featuredImage size-featuredImage" alt="Lung cancer cell" loading="lazy" srcset="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg 620w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-300x168.jpg 300w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-220x123.jpg 220w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18781" data-permalink="https://news.cancerresearchuk.org/2020/09/11/targeted-drug-for-lung-cancer-approved-for-nhs-use-in-england/lung_cell_cropped-hero/"...

Touching a nerve: How neuroscience could advance our understanding of cancer

KTSDESIGN/SCIENCE PHOTO LIBRARY When supporters donate to our work, their combined generosity might lead to a new discovery that inches us closer to, for example,...

Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients with CUP

An investigator-initiated phase II study is the first to show that nivolumab has clinical activity with manageable toxicity in a statistically evaluable number of...